Mary L. Durbin

University of California, Irvine — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

22h-index2.3kcitations45works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(8), Plant Gene Expression Analysis(8), Cancer Research and Treatments(7), Genomics and Phylogenetic Studies(6), Plant and animal studies(6)

Publications45 total

Data from Malignant Pleural Mesothelioma–Targeted CREBBP/EP300 Inhibitory Protein 1 Promoter System for Gene Therapy and Virotherapy
2023Open Access
Supplementary Figure 1 from Malignant Pleural Mesothelioma–Targeted CREBBP/EP300 Inhibitory Protein 1 Promoter System for Gene Therapy and Virotherapy
2023Open Access
Data from Malignant Pleural Mesothelioma–Targeted CREBBP/EP300 Inhibitory Protein 1 Promoter System for Gene Therapy and Virotherapy
2023Open Access
Supplementary Figure 1 from Malignant Pleural Mesothelioma–Targeted CREBBP/EP300 Inhibitory Protein 1 Promoter System for Gene Therapy and Virotherapy
2023Open Access
Quantitative Trait Locus Analysis in Avocado: The Challenge of a Slow-maturing Horticultural Tree Crop
Journal of the American Society for Horticultural Science·2019· 8 citedOpen Access
Quantitative Genetic Analysis of Three Important Nutritive Traits in the Fruit of Avocado
Journal of the American Society for Horticultural Science·2013· 18 citedOpen Access
Tracing the Geographic Origins of Weedy Ipomoea purpurea in the Southeastern United States
Journal of Heredity·2013· 13 citedOpen Access
Abstract 5701: Targeting KRAS lung cancer in vivo by pulmonary surfactant-mediated gene transfer
Cancer Research·2012
Nucleotide Sequence Diversity of Floral Pigment Genes in Mexican Populations of Ipomoea purpurea (Morning Glory) Accord with a Neutral Model of Evolution
Journal of Heredity·2012· 3 cited
Targeting KRAS mutation-bearing lung cancer in vivo by pulmonary surfactant-adenovirus-mediated gene transfer.
PubMed·2010· 4 cited
Anti-Tumor Effect in Human Lung Cancer by a Combination Treatment of Novel Histone Deacetylase Inhibitors: SL142 or SL325 and Retinoic Acids
PLoS ONE·2010· 26 citedOpen Access
Inhibition of Myc effectively targets KRAS mutation-positive lung cancer expressing high levels of Myc.
PubMed·2010· 32 cited
Abstract 603: Adenoviral mediated expression of Omomyc induced growth inhibition and apoptosis in lung cancer expressing Myc
Cancer Research·2010· 2 cited
Extensive evolutionary rate variation in floral color determining genes in the genus <i>Ipomoea</i>
Plant Species Biology·2010· 16 cited
Adenovirus-mediated cancer gene therapy and virotherapy (Review).
PubMed·2010· 59 cited
Drug‐regulatable cancer cell death induced by BID under control of the tissue‐specific, lung cancer‐targeted TTS promoter system
International Journal of Cancer·2009· 7 citedOpen Access
Malignant Pleural Mesothelioma–Targeted CREBBP/EP300 Inhibitory Protein 1 Promoter System for Gene Therapy and Virotherapy
Cancer Research·2008· 16 citedOpen Access
Malignant pleural mesothelioma-targeted CRI1 promoter system for gene therapy and virotherapy
Cancer Research·2008
Malignant pleural mesothelioma-targeted gene therapy
2007
Pulmonary adenocarcinoma–targeted gene therapy by a cancer- and tissue-specific promoter system
Molecular Cancer Therapeutics·2007· 23 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Michael T. Clegg(20), Takuya Fukazawa(18), Junji Matsuoka(16), Yoshio Naomoto(16), Yutaka Maeda(12), Noriaki Tanaka(10), Tomoki Yamatsuji(6), Lowell N. Lewis(5), R. Sexton(4), Hirotoshi Tanaka(4), Yutaka Maeda(4), Gavin Huttley(3), L. N. Lewis(3), Ichiro Morita(3), Toru Nakai(3), Kapua K.T. Meyer(3), Edward M. Golenberg(2), John Doebley(2), Din Pow(2), Bonnie C. McCaig(2)